EGFR and neoplasm: In addition, regarding the growing understanding of the tumour–stroma interaction and the possible role of cancer-associated mesenchyme as a novel target for anticancer therapy, we also analysed the stroma of invasive breast adenocarcinomas for EGFR mutations.